Skip to main content
Article
Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system.
Cytometry Part B-clinical Cytometry (2020)
  • Charles Bruce Bagwell, Verity Software House Topsham Maine
  • Benjamin Hunsberger, Verity Software House Topsham Maine
  • Beth Hill, Verity Software House Topsham Maine
  • Donald Herbert, Verity Software House Topsham Maine
  • Christopher Bray, Verity Software House Topsham Maine
  • Thirumahal Selvanantham, Fluidigm Canada Inc. Markham Ontario Canada
  • Stephen Li, Fluidigm Canada Inc. Markham Ontario Canada
  • Jose C. Villasboas, Mayo Clinic
  • Kevin Pavelko, Mayo Clinic
  • Michael Strausbauch, Mayo Clinic
  • Adeeb Rahman, Icahn School of Medicine at Mount Sinai
  • Gregory Kelly, Icahn School of Medicine at Mount Sinai
  • Shahab Asgharzadeh, Children's Hospital Los Angeles
  • Azucena Gomez‐Cabrero, Children's Hospital Los Angeles
  • Gregory Behbehani, Ohio State University
  • Hsiaochi Chang, Ohio State University
  • Justin Lyberger, Ohio State University
  • Ruth Montgomery, Yale University
  • Yujiao Zhao, Yale University
  • Margaret Inokuma, Verity Software House Topsham Maine
  • Ofir Goldberger, Fluidigm Corporation
  • Greg Stelzer, Fluidigm Corporation
Publication Date
March 1, 2020
DOI
10.1002/CYTO.B.21858
Citation Information
Charles Bruce Bagwell, Benjamin Hunsberger, Beth Hill, Donald Herbert, et al.. "Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system." Cytometry Part B-clinical Cytometry Vol. 98 Iss. 2 (2020) p. 146 - 160
Available at: http://works.bepress.com/christopher-bray/4/